E-LIB Suche - Ergebnisse für: Mahon, François-Xavier

1

How to interpret the EURO-SKI study and its treatment-free ..:

Pfirrmann, Markus ; Saussele, Susanne ; Mahon, François-Xavier.
Leukemia. 38 (2024) 2 - p. 460-462 , 2024

Link: https://doi.org/10.1038/..

2

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRON..:

Efficace, Fabio ; Mahon, Francois-Xavier ; Richter, Johan...
HemaSphere. 7 (2023) S3 - p. e0972454 , 2023

Link: https://doi.org/10.1097/..

3

PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STU..:

Hochhaus, Andreas ; Saussele, Susanne ; Mahon, Francois-Xavier...
HemaSphere. 7 (2023) S3 - p. e5851092 , 2023

Link: https://doi.org/10.1097/..

4

Asciminib monotherapy in patients with CML-CP without BCR::..:

Mauro, Michael J. ; Hughes, Timothy P. ; Kim, Dong-Wook...
Leukemia. 37 (2023) 5 - p. 1048-1059 , 2023

Link: https://doi.org/10.1038/..

5

POSTER: CML-590 ASC4START: A Phase 3b, Open-Label, Randomiz..:

Strickland, Stephen ; Andorsky, David ; Brümmendorf, Tim...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S178 , 2023

Link: https://doi.org/10.1016/..

6

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONS..:

Pfirrmann, Markus ; Mahon, Francois-Xavier ; Dulucq, Stéphanie...
HemaSphere. 7 (2023) S3 - p. e230884b , 2023

Link: https://doi.org/10.1097/..

7

CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study..:

Strickland, Stephen ; Andorsky, David ; Brümmendorf, Tim...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S349-S350 , 2023

Link: https://doi.org/10.1016/..

8

Poster: CML-466 Asciminib Provides Durable Molecular Respon..:

Hughes, Timothy P. ; Cortes, Jorge E. ; Réa, Delphine...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S146 , 2022

Link: https://doi.org/10.1016/..

9

Antimetabolic cooperativity with the clinically approved l-..:

Trinh, Anne ; Khamari, Raeeka ; Fovez, Quentin...
Molecular Metabolism. 55 (2022) - p. 101410 , 2022

Link: https://doi.org/10.1016/..

10

CML-466 Asciminib Provides Durable Molecular Responses in P..:

Hughes, Timothy P. ; Cortes, Jorge E. ; Réa, Delphine...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S300 , 2022

Link: https://doi.org/10.1016/..

11

Onset of blast crisis in chronic myeloid leukemia patients ..:

Dulucq, Stephanie ; Hayette, Sandrine ; Cayuela, Jean-Michel...
Haematologica. 107 (2022) 12 - p. 2944-2949 , 2022

Link: https://doi.org/10.3324/..

12

Kinetics of early and late molecular recurrences after firs..:

Dulucq, Stéphanie ; Nicolini, Franck E. ; Rea, Delphine...
Haematologica. 107 (2022) 12 - p. 2859-2869 , 2022

Link: https://doi.org/10.3324/..

13

Imatinib Optimized Therapy Improves Major Molecular Respons..:

Johnson-Ansah, Hyacinthe ; Maneglier, Benjamin ; Huguet, Françoise...
Pharmaceutics. 14 (2022) 8 - p. 1676 , 2022

Link: https://doi.org/10.3390/..

14

Preclinical evaluation of Imatinib does not support its use..:

Touret, Franck ; Driouich, Jean-Sélim ; Cochin, Maxime...
Antiviral Research. 193 (2021) - p. 105137 , 2021

Link: https://doi.org/10.1016/..

15

Budget Impact of Tyrosine Kinase Inhibitor Discontinuation ..:

Astrugue, Cyril ; Bénard, Antoine ; Bosco-Levy, Pauline...
Value in Health. 24 (2021) 5 - p. 683-690 , 2021

Link: https://doi.org/10.1016/..